Dr. Drappatz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
# Upmc
Pittsburgh, PA 15232Phone+1 412-623-7955
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2004 - 2005- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
Boston University Medical CenterInternship, Internal Medicine, 2000 - 2001
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2011 - 2024
MA State Medical License 2004 - 2012- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Member Best Doctors
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.Jann N Sarkaria, Karla V Ballman, Sani H Kizilbash, Erik P Sulman, Caterina Giannini
JAMA Oncology. 2024-10-31 - Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM.Michal Nisnboym, Chaim T Sneiderman, Ambika P Jaswal, Zujian Xiong, Sarah R Vincze
Expert Review of Clinical Immunology. 2024-10-14 - Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng
Clinical Cancer Research. 2024-08-01
Other
- Seizures in patients with primary and metastatic brain tumorsDrappatz J, Avila EK, Wen PY
http://www.uptodate.com/contents/seizures-in-patients-with-primary-and-metastatic-brain-tumors
UpToDate, Wolters Kluwer Health - 2013-04-03 - Management of vasogenic edema in patients with primary and metastatic brain tumorsDrappatz J, Wen PY
http://www.uptodate.com/contents/management-of-vasogenic-edema-in-patients-with-primary-and-metastat
UpToDate, Wolters Kluwer Health - 2013-02-13 - Systemic therapy for brain metastasesDrappatz J, Wen PY
http://www.uptodate.com/contents/systemic-therapy-for-brain-metastases
UpToDate, Wolters Kluwer Health - 2012-12-07
Press Mentions
Benefits of WBRT for Brain MetastasesAugust 2nd, 2019
New Molecule Found to Cross the Blood‐Brain Barrier: Reporte... : Neurology TodayFebruary 28th, 2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
